Your browser doesn't support javascript.
Geographical distribution of TTS cases following AZD1222 (ChAdOx1 nCoV-19) vaccination.
Soboleva, Karina; Shankar, Nirmal Kumar; Yadavalli, Madhavi; Ferreira, Cátia; Foskett, Nadia; Putsepp, Kert; Ferstenberg, Lisa Beth; Nord, Magnus; da Silva, Hugo Gomes; Bhuyan, Prakash.
  • Soboleva K; Clinical Development, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA.
  • Shankar NK; Patient Safety, Chief Medical Office, R&D, AstraZeneca India, Bangalore, India.
  • Yadavalli M; Patient Safety, Chief Medical Office, R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Ferreira C; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA.
  • Foskett N; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
  • Putsepp K; BioPharmaceuticals, AstraZeneca, Gaithersburg, MD, USA.
  • Ferstenberg LB; Patient Safety, Chief Medical Office, R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Nord M; Patient Safety, Chief Medical Office, R&D, AstraZeneca, Gothenburg, Sweden.
  • da Silva HG; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
  • Bhuyan P; Clinical Development, Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. Electronic address: prakash.bhuyan@astrazeneca.com.
Lancet Glob Health ; 10(1): e33-e34, 2022 01.
Article in English | MEDLINE | ID: covidwho-1586167
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombocytopenia / Thrombosis / COVID-19 / ChAdOx1 nCoV-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Lancet Glob Health Year: 2022 Document Type: Article Affiliation country: S2214-109X(21)00545-3

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombocytopenia / Thrombosis / COVID-19 / ChAdOx1 nCoV-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Lancet Glob Health Year: 2022 Document Type: Article Affiliation country: S2214-109X(21)00545-3